1-(alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7pyridinyl-imidazo(1,2-a)pyrimidin-5(1H)-one derivatives

Details for Australian Patent Application No. 2002212248 (hide)

International Classifications

Event Publications

24 February 2005 Change of Name(s) of Applicant(s), Section 104

Sanofi-Synthelabo The name of the applicant has been changed to Mitsubishi Pharma Corporation; Sanofi-Aventis

4 January 2007 Application Accepted

Published as AU-B-2002212248

3 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.